NSILICO LIFE SCIENCE LIMITED

Their core work

nSilico Life Science is an Irish computational biology SME ("in silico" = computer-based biological analysis) specializing in bioinformatics software and data integration for life sciences. Their work spans two distinct application domains: clinical genomics — specifically linking genomic data to electronic health records to support cancer diagnosis and treatment — and environmental metagenomics, where they build accessible software platforms for analyzing microbial communities in agricultural settings. Their core value proposition is translating complex biological datasets into usable platforms and tools, bridging raw omics data and practical scientific or clinical workflows.

What they specialise in

How they've shifted over time

Both H2020 projects were active concurrently in 2015–2018, making it difficult to draw a clean before/after trajectory — this is an organization with a short, dense burst of EU-funded activity rather than a long arc of evolution. Their earliest project (SAGE-CARE, 2014) tackled clinical informatics and cancer genomics, while MetaPlat (2015) pivoted to environmental and agricultural metagenomics — suggesting breadth of application rather than deep specialization in a single vertical. No keywords were available in the dataset to confirm or refine this reading, so the evolution assessment is inferred from project titles alone.

With no H2020 activity after 2015 and both projects completed by 2019, nSilico appears to have exited EU-funded research or shifted to commercial product development — a potential collaborator for applied bioinformatics tooling rather than frontier research.

How they like to work

nSilico has participated exclusively as a consortium partner, never as a project coordinator — consistent with a small SME that contributes specialist technical capability rather than managing consortia. With only 7 unique partners across 4 countries and 2 projects, their network is limited and does not suggest a well-connected hub. They appear to join focused, specialist consortia where their computational tooling expertise fills a specific gap.

nSilico has collaborated with 7 unique partners across 4 countries, entirely through MSCA-RISE staff exchange consortia. Their network is narrow and geographically limited, with no evident repeat partnerships or a dominant country cluster visible from the data.

What sets them apart

nSilico occupies an unusual dual-domain position in computational biology: one foot in clinical health informatics (genomics + EHR for cancer) and one in environmental science (agricultural metagenomics), which is uncommon for a micro-SME. Their focus on usability — "easy-to-use" platforms — suggests they build tools for non-expert end users, not just researchers, which differentiates them from academic bioinformatics groups. For consortium builders, they are most valuable when a project needs a dedicated software development partner who can translate complex biological analysis into deployable tools.

Highlights from their portfolio

• MetaPlat
  The largest-funded project (€315,000) and notable for applying metagenomics — a genomic sequencing technique — to agricultural science, an unusual cross-disciplinary combination that signals applied product ambition.
• SAGE-CARE
  Tackles semantic interoperability between genomics and electronic health records for cancer — a technically complex data integration challenge with direct clinical relevance.